Source: PR-Inside

Press Release: Pfizer : CERE Class Action Alert: Robbins LLP Reminds Investors of the Lead ...

(PR-inside.com) SAN DIEGO, CA / ACCESS Newswire / April 9, 2025 /Robbins LLP reminds stockholders that a class action was filed against Cerevel Therapeutics Holdings, Inc. ("Cerevel" or the "Company"), Bain Capital Investors, LLC ("Bain") and Pfizer, Inc. ("Pfizer") on behalf of a class (the "Class") consisting of all persons or entities that: (a) sold or otherwise disposed of the publicly-traded common stock of Cerevel (NASDAQ:CERE) during the period from October 11, 2023 through August 1, 2024, inclusive, and thus were damaged by defendants' violations of Section 10(b) of the Securities Exchange Act of 1934 ("Exchange Act"); (b) held shares of Cerevel ..

Read full article »
Annual Revenue
$50-100B
Employees
50-100K
Albert Bourla's photo - Chairman & CEO of Pfizer

Chairman & CEO

Albert Bourla

CEO Approval Rating

69/100

Read more